Plan-les-Ouates, Switzerland

Andre Chollet

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 1.3

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Andre Chollet

Introduction

Andre Chollet is a notable inventor based in Plan-les-Ouates, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral formulations and receptor antagonists. With a total of seven patents to his name, Chollet's work is focused on addressing critical health issues.

Latest Patents

Chollet's latest patents include innovative oral formulations of pyrrolidine derivatives. These formulations comprise a specific compound designed to treat and prevent preterm labor, premature birth, dysmenorrhea, and embryo implantation failure due to uterine contractions. Additionally, he has developed pyrrolidine derivatives that act as antagonists at the oxytocin and vasopressin V1a receptors. These inventions not only highlight his expertise but also his commitment to advancing medical treatments.

Career Highlights

Chollet is currently associated with Obseva S.A., a company dedicated to developing novel therapies for women's reproductive health. His work at Obseva has positioned him as a key player in the pharmaceutical industry, contributing to groundbreaking research and development.

Collaborations

Chollet has collaborated with notable colleagues, including Oliver Pohl and Olivier Pohl. These partnerships have fostered a collaborative environment that enhances innovation and drives the development of new therapeutic solutions.

Conclusion

Andre Chollet's contributions to the field of pharmaceuticals through his patents and collaborations underscore his role as an influential inventor. His work continues to pave the way for advancements in women's health and medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…